Gupta Rishi
SEC CIK 1537370 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ELVN | Enliven Therapeutics, Inc. | Dir, 10% | 7.66M | — | $22.88M | 3 | 2023-02-23 | 2024-05-16 |
Most active insiders at ELVN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ORBIMED ADVISORS LLC | 10% | — | $51.68M |
| 2 | Derynck Mika K | Dir | — | $9.56M |
| 3 | Collins Helen Louise | Chief MEDICAL Off | — | $5.39M |
| 4 | Lyssikatos Joseph P | CSO | — | $4.88M |
| 5 | Patel Anish | COO | — | $1.74M |
| 6 | Hohl Benjamin | CFO | — | $1.60M |
| 7 | Kunkel Lori Anne | Dir | — | $850.3K |
| 8 | Kintz Samuel | Pres AND CEO, Dir | — | $613.6K |
| 9 | Heyman Richard A. | Dir | — | $413.4K |
Gupta Rishi made no open-market trades at ELVN in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-05-20 | 2024-05-16 | ELVN | Enliven Therapeutics, Inc. | Gupta Rishi | Dir, 10% | S - Sale | $22.14 | -1.03M | 7.66M | -12% | -$22.88M |
| DI | 2023-05-19 | 2023-05-17 | ELVN | Enliven Therapeutics, Inc. | Gupta Rishi | Dir, 10% | M - OptEx | $4.28 | +2,125 | 8.66M | +0.0% | +$9,095 |
| MI | 2023-02-27 | 2023-02-23 | ELVN | Enliven Therapeutics, Inc. | Gupta Rishi | Dir, 10% | A - Grant | — | +7.90M | 288.1K | New | — |
Purchase Sale Sale after option exercise All abbreviations